BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2652732)

  • 1. Lymphocyte parameters in liver graft recipients receiving prophylactic OKT3 or conventional triple therapy.
    Hamilton G; Mühlbacher F; Steininger R; Havel M; Kreuzer S; Laengle F; Piza F
    Transplant Proc; 1989 Feb; 21(1 Pt 2):2255-6. PubMed ID: 2652732
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunohistology of liver allografts in recipients managed with prophylactic OKT3.
    Rohrer RJ; Jenkins RL; Khettry U; Pinson CW; Gallik-Karlson C; Monaco AP
    Transplant Proc; 1989 Feb; 21(1 Pt 2):2249-50. PubMed ID: 2652729
    [No Abstract]   [Full Text] [Related]  

  • 3. Use of OKT3 in kidney, pancreas, and liver transplantation.
    D'Alessandro AM; Pirsch JD; Melzer JS; Sollinger HW; Kalayoglu M; Reed A; Knechtle SJ; Belzer FO
    Transplant Proc; 1990 Aug; 22(4):1748-9. PubMed ID: 2117796
    [No Abstract]   [Full Text] [Related]  

  • 4. Low serum OKT3 levels correlate with failure to prevent rejection in orthotopic liver transplant patients.
    McDiarmid SV; Millis M; Terashita G; Ament ME; Busuttil R; Terasaki P
    Transplant Proc; 1990 Aug; 22(4):1774-6. PubMed ID: 2117806
    [No Abstract]   [Full Text] [Related]  

  • 5. Triple drug therapy: an alternative regimen in renal transplantation.
    Henry ML; Sommer BG; Ferguson RM
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1920-1. PubMed ID: 3079059
    [No Abstract]   [Full Text] [Related]  

  • 6. Early detection of viral infection in liver graft recipients by immune monitoring.
    Hamilton G; Popov T; Mühlbacher F; Piza F
    Transplant Proc; 1989 Feb; 21(1 Pt 2):2266-7. PubMed ID: 2540566
    [No Abstract]   [Full Text] [Related]  

  • 7. Impacts of low-dose steroids and prophylactic monoclonal versus polyclonal antibodies on acute rejection in cyclosporine- and azathioprine-immunosuppressed cardiac allografts.
    Laufer G; Laczkovics A; Wollenek G; Schreiner W; Sochor H; Holzinger C; Buchelt M; Fasol R; Wolner E
    J Heart Transplant; 1989; 8(3):253-61. PubMed ID: 2661776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single center randomized trial using ATG v OKT3 treatment in steroid resistant rejection crises after kidney transplantation.
    Blümke M; Kirste G; Wanner U; Wilms H
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1747. PubMed ID: 2652571
    [No Abstract]   [Full Text] [Related]  

  • 9. Histologic response to OKT3 therapy for hepatic allograft rejection.
    Rohrer RJ; Jenkins RL; Khettry U; Benotti PN; Dodson TF; Karlson CG; Georgi BA; Monaco AP
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2459-61. PubMed ID: 3079086
    [No Abstract]   [Full Text] [Related]  

  • 10. Alternative immunosuppressive strategies in the management of recipients of living related renal transplants.
    Hodge E; Banowsky L; Novick A; Lewis R; Streem S; Steinmuller D; Holzmann J; McFarlin L; Graneto D; Medendorp SV
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1609-14. PubMed ID: 2652524
    [No Abstract]   [Full Text] [Related]  

  • 11. Cyclosporine-steroids versus conventional therapy in cadaver kidney transplantation: analysis of a randomized trial at two years.
    Gianello P; Squifflet JP; Pirson Y; Stoffel M; Dereme T; Alexandre GP
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1867-72. PubMed ID: 3547891
    [No Abstract]   [Full Text] [Related]  

  • 12. Management of immunosuppressive problems in renal allograft recipients.
    Lorber MI; Flechner SM; Van Buren CT; Sorensen K; Kerman RH; Kahan BD
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1951-4. PubMed ID: 3547899
    [No Abstract]   [Full Text] [Related]  

  • 13. OKT3 immunoprophylaxis in human liver transplantation.
    Mühlbacher F; Steininger R; Längle F; Sautner T; Gnant M; Götzinger P; Piza F; Popow T
    Transplant Proc; 1989 Feb; 21(1 Pt 2):2253-4. PubMed ID: 2652731
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunosuppression in cardiac transplantation.
    Rose EA; Addonizio LJ
    Bibl Cardiol; 1988; (43):1-9. PubMed ID: 3067706
    [No Abstract]   [Full Text] [Related]  

  • 15. Control of rejection of transplanted organs.
    Keown PA; Stiller CR
    Adv Intern Med; 1986; 31():17-46. PubMed ID: 3511616
    [No Abstract]   [Full Text] [Related]  

  • 16. Concomitant low-dose cyclosporine and OKT3 therapy for renal transplant rejection.
    Hricik DE; Zarconi J; Schulak JA
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1755-7. PubMed ID: 2652574
    [No Abstract]   [Full Text] [Related]  

  • 17. The role of antilymphocyte globulin in cadaver renal transplantation.
    Novick AC
    Transplant Proc; 1986 Jun; 18(3 Suppl 2):22-7. PubMed ID: 3521000
    [No Abstract]   [Full Text] [Related]  

  • 18. Infection and rejection of primary hepatic transplant in 93 consecutive patients treated with triple immunosuppressive therapy.
    Ascher NL; Stock PG; Bumgardner GL; Payne WD; Najarian JS
    Surg Gynecol Obstet; 1988 Dec; 167(6):474-84. PubMed ID: 3055368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum beta 2 microglobulin levels are relatively depressed in cyclosporine A-treated patients who undergo kidney graft rejection.
    Kootte AM; Henny FC; Moolenaar AJ; van Es LA; Paul LC
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1681-2. PubMed ID: 3079033
    [No Abstract]   [Full Text] [Related]  

  • 20. Identification and function of a major OKT3, OKT8, Leu-7, positive lymphocyte subpopulation in renal transplant recipients treated with total lymphoid irradiation.
    Waer M; Vanrenterghem Y; Van der Schueren E; Michielsen P; Vandeputte M
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1570-1. PubMed ID: 3079027
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.